Medical Capital Investigation

Aidikoff, Uhl & Bakhtiari (www.securitiesarbitration.com) announces an investigation of Medical Capital on behalf of investors in Medical Capital securities. The law firm has been contacted by investors and is
preparing to file FINRA arbitration claims against broker dealers and
possibly investment advisors firms for losses incurred based on the
recommendation to purchase Medical Capital securities.

The individual brokers and individual advisors who sold Medical Capital
are not targets of investor claims.

Medical Capital Corporation and Medical Provider Funding Corporation VI
raised more than $2.2 billion through the offering of notes in Medical
Provider Funding Corp VI and earlier special purpose entity offerings.

On August 3, 2009 the Securities and Exchange Commission (SEC) sought
emergency relief. The SEC has alleged that investors were defrauded
among other things, by Medical Capital's misappropriation of
approximately $18.5 million of the $76.9 million raised through the
sale of MP VI notes to pay administrative fees to MCC.

"The SEC has taken steps to prevent future capital raises from taking
place," stated attorney Philip M. Aidikoff. "However, this will not
help the thousands of investors who have lost millions of dollars by
virtue of the recommendation of Medical Capital related securities."

"We are investigating claims for customers of Securities America,
National Securities, American Portfolio Financial Services and other
broker dealers," stated attorney Ryan K. Bakhtiari. "Brokerage firms
owe a duty to conduct proper due diligence of investments before they
approve the recommendation of them to their clients. We believe that
clients of brokerage firms may have recourse."

Aidikoff, Uhl & Bakhtiari represents retail and institutional investors
around the world in securities arbitration and litigation matters. More
information is available at www.securitiesarbitration.com or by
contacting an attorney below.